Works cited by this work

149 works

Work: Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments

Hallmarks of Cancer: The Next Generation
Douglas Hanahan, Robert A. Weinberg
Review article201118 citations
ABI
Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs
Hamzeh J. Al‐Ameer, Malek Zihlif, Ahmed O. Maslat +13
Article202510 citations
ABI
The role of regulatory T cells in the pathogenesis and treatment of prostate cancer
Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6
Review article20216 citations
ABI
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67
Article20176 citations
ABI
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells
Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12
Article20215 citations
ABI
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer
Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7
Review article20195 citations
ABI
EP4 receptor as a novel promising therapeutic target in colon cancer
Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5
Review article20205 citations
ABI
The role of Th17 cells in the pathogenesis and treatment of breast cancer
Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi +5
Review article20225 citations
ABI
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11
Article20245 citations
ABI
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang +32
Article20155 citations
ABI
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide
Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13
Article20234 citations
ABI
RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11
Article20214 citations
ABI
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary +4
Review article20234 citations
ABI
The molecular biology and therapeutic potential of Nrf2 in leukemia
Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6
Review article20224 citations
ABI
TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer
Laura García Pérez, Jan Kempski, Heather M. McGee +21
Article20203 citations
ABI
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
Thierry André, Kai‐Keen Shiu, Tae Won Kim +18
Article20203 citations
ABI
T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer
Mehrdad Fathi, Inna Pustokhina, Sergey V. Kuznetsov +5
Review article20213 citations
ABI
Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer
Sepideh Izadi, Mohammad Hojjat Farsang, Vahid Karpisheh +1
Article20233 citations
ABI
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1
Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13
Article20253 citations
ABI
Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
Jieru Zhou, Xiaoduan Li, Xiaoli Wu +7
Article20182 citations
ABI
Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells
Koji Atarashi, Takeshi Tanoue, Minoru Ando +28
Article20152 citations
ABI
A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)
Naohiro Yoshida, Tetsushi Kinugasa, Hiroaki Miyoshi +8
Article20152 citations
ABI
Colonic neoplasia in patients with nonspecific GI symptoms
David A. Lieberman, Patricia L. de Garmo, David E. Fleischer +3
Article20002 citations
ABI
Neoadjuvant<i>vs</i>adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior?
Sarah Popek
Review article20112 citations
ABI
In vitro DNA adduct profiling to mechanistically link red meat consumption to colon cancer promotion
Lieselot Hemeryck, Caroline Rombouts, Thomas Van Hecke +4
Article20162 citations
ABI